Correlation Between Westaim Corp and Arch Biopartners
Can any of the company-specific risk be diversified away by investing in both Westaim Corp and Arch Biopartners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Westaim Corp and Arch Biopartners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Westaim Corp and Arch Biopartners, you can compare the effects of market volatilities on Westaim Corp and Arch Biopartners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Westaim Corp with a short position of Arch Biopartners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Westaim Corp and Arch Biopartners.
Diversification Opportunities for Westaim Corp and Arch Biopartners
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Westaim and Arch is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Westaim Corp and Arch Biopartners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Biopartners and Westaim Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Westaim Corp are associated (or correlated) with Arch Biopartners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Biopartners has no effect on the direction of Westaim Corp i.e., Westaim Corp and Arch Biopartners go up and down completely randomly.
Pair Corralation between Westaim Corp and Arch Biopartners
Assuming the 90 days horizon Westaim Corp is expected to generate 0.91 times more return on investment than Arch Biopartners. However, Westaim Corp is 1.1 times less risky than Arch Biopartners. It trades about 0.02 of its potential returns per unit of risk. Arch Biopartners is currently generating about -0.04 per unit of risk. If you would invest 3,138 in Westaim Corp on December 29, 2024 and sell it today you would earn a total of 37.00 from holding Westaim Corp or generate 1.18% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Westaim Corp vs. Arch Biopartners
Performance |
Timeline |
Westaim Corp |
Arch Biopartners |
Westaim Corp and Arch Biopartners Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Westaim Corp and Arch Biopartners
The main advantage of trading using opposite Westaim Corp and Arch Biopartners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Westaim Corp position performs unexpectedly, Arch Biopartners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Biopartners will offset losses from the drop in Arch Biopartners' long position.Westaim Corp vs. Pulse Seismic | Westaim Corp vs. Quarterhill | Westaim Corp vs. Kneat Inc | Westaim Corp vs. Trisura Group |
Arch Biopartners vs. NervGen Pharma Corp | Arch Biopartners vs. Nanalysis Scientific Corp | Arch Biopartners vs. Perimeter Medical Imaging | Arch Biopartners vs. Medicenna Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Global Correlations Find global opportunities by holding instruments from different markets |